Authors:
Grunder, G
Siessmeier, T
Lange-Asschenfeldt, C
Vernaleken, I
Buchholz, HG
Stoeter, P
Drzezga, A
Luddens, H
Rosch, F
Bartenstein, P
Citation: G. Grunder et al., [F-18]fluoroethylflumazenil: a novel tracer for PET imaging of human benzodiazepine receptors, EUR J NUCL, 28(10), 2001, pp. 1463-1470
Authors:
Bartenstein, P
Grunwald, F
Kuwert, T
Tatsch, K
Sabri, O
Benkert, O
Fahlbusch, R
Grunder, G
Herholz, K
Weiller, C
Citation: P. Bartenstein et al., Clinical applications of single photon emission tomography in neuromedicine - Part 2: dementia, psychotic disorders, inflammation, trauma, NUKLEARMED, 39(8), 2000, pp. 218-232
Authors:
Bartenstein, P
Grunwald, F
Kuwert, T
Tatsch, K
Sabri, O
Benkert, O
Fahlbusch, R
Grunder, G
Herzholz, K
Weiller, C
Citation: P. Bartenstein et al., Clinical applications of single photon emission tomography in neuromedicine Part 1: Neuro-oncology, epilepsy, movement disorders, cerebrovascular disease, NUKLEARMED, 39(7), 2000, pp. 180-195
Authors:
Grunder, G
Muller, MJ
Andreas, J
Heydari, N
Wetzel, H
Schlosser, R
Schlegel, S
Nickel, O
Eissner, D
Benkert, O
Citation: G. Grunder et al., Occupancy of striatal D-2-like dopamine receptors after treatment with thesigma ligand EMD 57445, a putative atypical antipsychotic, PSYCHOPHAR, 146(1), 1999, pp. 81-86
Authors:
Muller, MJ
Grunder, G
Wetzel, H
Muller-Siecheneder, F
Marx-Dannigkeit, P
Benkert, O
Citation: Mj. Muller et al., Antipsychotic effects and tolerability of the sigma ligand EMD 57445 (panamesine) and its metabolites in acute schizophrenia: an open clinical trial, PSYCHIAT R, 89(3), 1999, pp. 275-280